Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users
about
HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community careMetropolitan social environments and pre-HAART/HAART era changes in mortality rates (per 10,000 adult residents) among injection drug users living with AIDSBurden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the communityRelationship between food insecurity and mortality among HIV-positive injection drug users receiving antiretroviral therapy in British Columbia, CanadaClinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.Confronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from MalaysiaPublic health and international drug policy.Increases in CD4+ T-cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada.Housing status and the health of people living with HIV/AIDSUnderstanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jailMethadone maintenance therapy decreases the rate of antiretroviral therapy discontinuation among HIV-positive illicit drug users.Employment predicts decreased mortality among HIV-seropositive illicit drug users in a setting of universal HIV careRelationship between hunger, adherence to antiretroviral therapy and plasma HIV RNA suppression among HIV-positive illicit drug users in a Canadian setting.Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study.Employment and risk of injection drug use initiation among street involved youth in Canadian setting.Physician experience and rates of plasma HIV-1 RNA suppression among illicit drug users: an observational study.Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study.High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting."What makes you think you have special privileges because you are a police officer?" A qualitative exploration of police's role in the risk environment of female sex workers.Incarceration is associated with used syringe lending among active injection drug users with detectable plasma HIV-1 RNA: a longitudinal analysis.Incarceration of people living with HIV/AIDS: implications for treatment-as-prevention.Incarceration and health outcomes in HIV-infected patients: the impact of substance use, primary care engagement, and antiretroviral adherenceChallenges in managing HIV in people who use drugsCompulsory drug detention exposure is associated with not receiving antiretroviral treatment among people who inject drugs in Bangkok, Thailand: a cross-sectional studyImpact of binge alcohol on mortality among people who inject drugs.Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug usersSocioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting.Childhood sexual abuse and risk for initiating injection drug use: a prospective cohort study.A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugsStructural Barriers to Antiretroviral Therapy Among Sex Workers Living with HIV: Findings of a Longitudinal Study in Vancouver, CanadaLow prevalence of antiretroviral resistance among HIV type 1-positive prisoners in the Southeast United States.Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention InitiativeSex-Based Differences in Rates, Causes, and Predictors of Death Among Injection Drug Users in Vancouver, Canada.Factors associated with initiation of antiretroviral therapy among HIV-positive people who use injection drugs in a Canadian settingFactors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian settingThe Impact of Benzodiazepine Use on Mortality Among Polysubstance Users in Vancouver, Canada.Correlates of retention in HIV care after release from jail: results from a multi-site study.
P2860
Q27014885-31BC4CF9-A625-4E40-930D-B441ABDCDED4Q28486380-AA6B49A9-10D5-4B87-A375-0E3825BB815EQ28488313-5ED1082D-7B8A-4350-8336-87717254EC7DQ28533313-44D617DA-AF18-486B-BA8B-BC1931DE363CQ30248944-1DDFA1C3-DA8F-4589-B78E-DBE446C97411Q30250218-A912AD54-6861-4DD7-9536-8E676EEB5003Q30377895-44C99926-C9D5-42DF-A0EC-42C838645BAFQ30399058-94FB3AEC-3735-4C12-9CBA-6F65D741C5C6Q30421169-2E3F5D00-E4B2-4050-9910-B47B3F9A485EQ33725810-02DA7C4A-AF38-4250-AAA4-C821090F1B6DQ33761440-8CA1FC82-F95A-40B5-8F2C-7476DF474212Q33768036-5A9699BC-4E74-4107-8B1D-418258B26CB6Q33782194-DF113303-29DB-4E45-9C2E-4CA0B0526D1AQ33916699-12E90348-7FE0-4337-B943-6C003BECBAB4Q34017185-FF1A30AA-404D-4A99-9560-718E368C6080Q34140927-A2EE70F0-9E88-48FF-9A78-D8FE1C91EC90Q34491134-0C007189-2192-4208-AD6E-C4A351AD9FF2Q34902580-1F56EFA4-F381-456D-A0E6-8F8DDD7FC678Q35033596-21C9560E-55BE-47A9-A0EF-998AC62B681CQ35056683-3EBFB0AC-32EB-4018-8B0C-4D3EF3D49BC0Q35194961-F111CE8F-D6DC-4796-AE65-7DBF81BE8724Q35418299-BC1D25D5-A87B-4BC5-82D5-CC867200A2A6Q35538674-53A2B574-CD65-4F39-8295-6D196E5D2016Q35618968-AB06C320-0098-4677-87D6-D106ABD6219AQ35751048-8815306F-6315-43C6-AF67-C3BC3FF666D7Q35823204-ABCAD90D-4F7C-48CA-8220-580EB11BD822Q35855263-DC13C1F3-7B8F-439C-B7FA-0233B321BB70Q36150095-EA5EF216-1706-4B78-BFBA-0DF7F7A76A37Q36284574-D298CEEA-079E-40C3-8C3C-9C178F5CFAB4Q36374041-919D8168-3C00-465C-B26C-D8386E9B5852Q36390767-6E936AD9-DC05-442C-9F39-897BAE978EA8Q36441211-DCDF7071-E725-49A5-9C5C-3ED554D80A0EQ36509584-10CBFDCF-FAED-49FB-8C2D-9C0293D4CFDCQ36543830-0359A305-C6CC-41D3-9007-8D2B54C79283Q36663552-C66C56B2-788E-4A09-9066-66D330AB489BQ36746200-3C36BE7C-C11D-405B-BAF8-125D750D6D9FQ36794581-999B862E-9A40-4F3C-A6F5-64A14FBED5AAQ36814748-B43A34ED-0D2A-4731-9E90-7024B3EB8936Q36906777-F8EEC034-A9F0-4B2D-9C98-DF65165954A3Q37022021-2917D721-AB0A-4AF6-B506-C0E08CBA7FC1
P2860
Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dose-response effect of incarc ...... apy among injection drug users
@ast
Dose-response effect of incarc ...... apy among injection drug users
@en
Dose-response effect of incarc ...... apy among injection drug users
@nl
type
label
Dose-response effect of incarc ...... apy among injection drug users
@ast
Dose-response effect of incarc ...... apy among injection drug users
@en
Dose-response effect of incarc ...... apy among injection drug users
@nl
prefLabel
Dose-response effect of incarc ...... apy among injection drug users
@ast
Dose-response effect of incarc ...... apy among injection drug users
@en
Dose-response effect of incarc ...... apy among injection drug users
@nl
P2093
P2860
P50
P356
P1476
Dose-response effect of incarc ...... apy among injection drug users
@en
P2093
Jane Buxton
M J Milloy
Silvia Guillemi
P2860
P304
P356
10.1093/INFDIS/JIR032
P407
P577
2011-05-01T00:00:00Z